Moderna (MRNA) stock rises as the company's Spikevax COVID-19 vaccine gets FDA approval for kids 6 months-11 years at higher ...

The placebo-controlled study is aimed at assessing the safety and efficacy of zodasiran in adults and adolescents with HoFH.

In recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

The Stowers Institute for Medical Research in Kansas City is one of the primary beneficiaries of The American Century ...

The human brain is comprised of two main types of cells, known as neurons and glia. The first are responsible for ...

These oils are, however, not full of hate, and there is a massive amount of peer-reviewed, rigorous evidence pointing to the contrary. Seed oils are linked to a reduction in inflammatory markers and ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

The FDA approves a rapid test for identifying patients with NSCLC eligible for sunvozertinib, enhancing timely, precision ...

PYC Therapeutics is set to begin Part B in its single ascending dose (SAD) study of the drug candidate, PYC-003, for ...

ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the ...